Shopping Cart
- Remove All
Your shopping cart is currently empty
Cefsulodin (SCE-129) exhibits strong efficacy against Pseudomonas aeruginosa and strains sensitive to penicillin and gentamicin, comparable to gentamicin and dibekacin. However, its effectiveness diminishes against penicillin-resistant Pseudomonas aeruginosa strains, particularly those also resistant to gentamicin. For Pseudomonas maltophilia, SCE-129 shows similar minimum inhibitory concentrations to penicillin, gentamicin, and dibekacin. Pseudomonas cepacia strains usually display moderate resistance to SCE-129 and penicillin, and high resistance to gentamicin and dibekacin.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks |
| Description | Cefsulodin (SCE-129) exhibits strong efficacy against Pseudomonas aeruginosa and strains sensitive to penicillin and gentamicin, comparable to gentamicin and dibekacin. However, its effectiveness diminishes against penicillin-resistant Pseudomonas aeruginosa strains, particularly those also resistant to gentamicin. For Pseudomonas maltophilia, SCE-129 shows similar minimum inhibitory concentrations to penicillin, gentamicin, and dibekacin. Pseudomonas cepacia strains usually display moderate resistance to SCE-129 and penicillin, and high resistance to gentamicin and dibekacin. |
| Synonyms | SCE-129 |
| Molecular Weight | 532.55 |
| Formula | C22H20N4O8S2 |
| Cas No. | 62587-73-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.